Searched for
AUROBINDO PHARMA Q2 RESULTS
Q2 earnings: Can India Inc repeat Q1, or will Q3 erase the base-effect tailwind?India Inc is likely to see a dip in earnings performance for Q2 in comparison to Q1, with analysts forecasting a growth slowdown of roughly...30 Sep, 2026, 12.43 PM IST- TCS, Wipro, other IT stocks rebound up to 6%, snapping 8-day losing streak. Why is Jefferies cautious?IT stocks rebounded on Wednesday, with TCS, Wipro and Coforge snapping an eight-session losing streak. The Nifty IT index rose nearly 3%, a...30 Sep, 2026, 11.51 AM IST
- SC seeks 16% MRP cap on medicines, flags huge cancer drug markupsThe Supreme Court has raised concerns regarding inflated prices of essential medicines, particularly cancer drugs, sold at exorbitant marku...30 Sep, 2026, 01.45 AM IST
- Ahead of Market: 10 things that will decide stock market action on WednesdayNifty’s indicative price plunged 2% in two seconds during the closing auction session on monthly expiry, before recovering sharply. Analyst...29 Sep, 2026, 11.29 PM IST
- Americans are struggling to find affordable used cars: Here's what a $10,000-$15,000 budget gets you in 2026Used-car buyers are encountering obstacles as they search for older models that come with increased mileage and higher prices. The pool of ...29 Sep, 2026, 10.48 PM IST
- Two Trades for Today: 2 mid-cap pharma stocks, one for a rise of 6.2%, and the other for a gain of almost 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...29 Sep, 2026, 10.02 PM IST
- Anupam Rasayan completes Bliss GVS deal, targets Rs 4,000-crore integrated platformAnupam Rasayan India Limited has finalised its acquisition of a controlling interest in Bliss GVS Pharma, marking a strategic expansion int...29 Sep, 2026, 12.10 PM IST
- Honasa Consumer shares fall 5% after Rs 643 crore block deal; Peak XV, Sequoia likely sellersHonasa Consumer shares declined up to 5% after 1.4 crore shares worth Rs 643 crore changed hands in a block deal. The transaction comes aft...29 Sep, 2026, 10.15 AM IST
- Auto stocks: Festive demand gets a low-base boost; can earnings justify valuations?The Indian automobile market is witnessing robust retail sales as the festive season draws near. A significant year-on-year uptick of 81.8%...29 Sep, 2026, 09.50 AM IST
- Sun Pharma, Aurobindo Pharma, other stocks in focus as Trump exempts India from 100% tariffs on some speciality drugsIndian pharma stocks, including Sun Pharma and Aurobindo Pharma, are in focus after the US exempted India and 19 other countries from 100% ...29 Sep, 2026, 08.56 AM IST
- Goldman Sachs sees Eternal achieving $1 billion EBITDA by FY29; raises target priceGoldman Sachs maintained a Buy rating on Eternal, formerly Zomato, raising its target price by 11% to Rs 385. The brokerage foresees Eterna...29 Sep, 2026, 08.30 AM IST
- Alaska has the shortest workweek in America, but it isn’t close to No. 1 for work-life balance; these US states are the best and worst for work-life balance in 2026Work-life balance: Remote’s 2025 Life-Work Balance Index compares all 50 states using factors such as average work hours, happiness, statut...28 Sep, 2026, 11.52 PM IST
- Shein returns to profit in second quarter, but warns of uncertain second halfAn increase in total orders fulfilled supported a more than 20% sequential jump in Shein's second-quarter net revenue, although the Iran co...28 Sep, 2026, 07.19 PM IST
- Sun Pharma signs major deal with LIB Therapeutics of US, gains access to $3.7-bn global market for bad cholesterol inhibitor PCSK9Sun Pharma has signed an exclusive agreement with LIB Therapeutics for Lerodalcibep, a cholesterol-lowering medication. This deal covers al...28 Sep, 2026, 11.48 AM IST
- Suzlon Energy shares fall 2% to near six-month low, down 15% in one monthSuzlon Energy shares slipped over 2% to a near six-month low, approaching their 52-week low amid higher trading volumes and broader market ...28 Sep, 2026, 11.41 AM IST
- Meesho shares rally 12% after UBS hikes target price by 24%. What’s keeping analysts bullish?UBS has raised its Meesho estimates across NMV, contribution profit and EBITDA, citing stronger seller and buyer growth and improving unit ...22 Sep, 2026, 12.14 PM IST
- JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?JM Financial retained Buy ratings on Dr Reddy’s Laboratories and Aurobindo Pharma, seeing up to 28% upside over the next 12 months. The bro...16 Sep, 2026, 02.39 PM IST
Load More
